THE PHYSIOLOGICAL EFFECTS OF ELECTROMAGNETIC EMISSIONS ON THE GENERAL CONDITION OF THE PATIENT
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Clinique Bizet
- Enrollment
- 37
- Locations
- 2
- Primary Endpoint
- Improved quality of life in depressed and anxiety patients: Hospital Anxiety and Depression scale
Study Overview
Brief Summary
Hospital patients usually experience anxiety caused by physiological, psychological and environmental stimuli. This emotional state corresponds to the psychophysiological response to a perceived threat.
The investigator's goal is to use a non-drug approach to these problems which would help improve the quality of life of patients, prevent the consumption of anti-anxiety drugs / antidepressants; and thus to reduce the direct cost in terms of treatment, but also to reduce the indirect costs linked to work stoppages and the consumption of the care offer.
Working hypothesis: Local magnetic muscle stimulation improves people's well-being and relaxation
Detailed Description
Primary objective :
Describe the effect of the intervention on the level of anxiety / depression in patients with anxious and / or depressive characteristics
Secondary objectives:
- Describe the variation in the quality of life of patients before and after the intervention
- Describe the variation in drug consumption
- Describe the use of post intervention hospitalization
- Describe the variation in the quality of sleep before and after the intervention
- Describe the timeframe for returning patients to professional activity
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Major patient hospitalized for the management of a chronic pathology and / or its complications;
- •Patient with a Hospital Anxiety and Depression scale score (HAD) ≥ 8 for items assessing anxiety disorders; AND a HAD score ≥ 8 for the items assessing depressive disorders.
- •Subject affiliated to a social security scheme or beneficiary of such a scheme
- •No participation in another clinical study
Exclusion Criteria
- •Minor patient
- •Pregnant and breastfeeding women
- •HAD score <8 for items evaluating anxiety disorders OR a HAD score <8 for items evaluating depressive disorders
- •Major subject protected by law, under curatorship or tutorship
Outcomes
Primary Outcomes
Improved quality of life in depressed and anxiety patients: Hospital Anxiety and Depression scale
Time Frame: Ten days
Evaluation with Hospital Anxiety and Depression scale
Improved quality of sleep: Epworth scale
Time Frame: Ten days
Evaluation with Epworth scale
Decreased consumption of anti-anxiety and anti-depressant drugs
Time Frame: Ten days
Prescription analysis
Secondary Outcomes
No secondary outcomes reported